Markets

  1. Home
Market Nav

GLENMARK PHARMACEUTICALS LTD.

  • NSE CodeGLENMARKEQ
  • BSE Code532296
  • ISININE935A01035
  • IndustryPharmaceuticals

Company Information

Management

Incorporation Year

18/11/1977

Registered Address


Mumbai, Maharashtra - 400026
Tel: 022-40189999, 40189879
Fax: 022-40189986

Registrar Office

KFIN Technologies Pvt. Ltd.
Selenium Tower B, Plot No. 31-32,Gachibowli, Financial District, Nanakramguda,Serilingampally Man
Hyderabad,500032,Telangana
Tel: 040-67161500
Fax: 23420814

Email

complianceofficer@glenmarkpharma.com

Website

http://www.glenmarkpharma.com

Listing

BSE, MCXSX, NSE

Corporate News

Glenmark to Launch Generic Leucovorin Calcium Injecti...

11-Dec-2025|3:29PM

Glenmark Pharmaceuticals announced on Thursday that it will introduce a gen

Glenmark Pharma - Announcement under Regulation 30 (L...

11-Dec-2025|8:44AM

Glenmark Pharmaceuticals Inc., USA to launch Leucovorin Calcium for Injecti

Glenmark Pharma - Press Release

11-Dec-2025|8:42AM

Glenmark Pharmaceuticals Limited has informed the Exchange regarding a pres

Glenmark Pharma - Update On The Company's Chhatrapati...

01-Dec-2025|8:57AM

Update on the Company's Chhatrapati Sambhajinagar (Aurangabad) Facility

More

Share Holding Pattern

Peer Comparison

Company NamePrice (₹)Market Cap(₹ Cr)
Aarey Drug65.34185.27
Aarti Drug392.853,585.54
Aarti Pharma757.306,864.72
Abbott India27,885.0059,253.68
Accent Micro342.95822.70
More

MF Holding

Scheme NameValue
(₹ Cr)		Holding (%)
HDFC Mi..2459.232.67
Invesco..389.001.41
Invesco..362.783.63
Invesco..360.061.75
Kotak A..352.800.48
More

Board Meetings

DatePurpose
14/11/2025Quarterly Results
26/09/2025Interim Dividend
14/08/2025Quarterly Results
23/05/2025Audited Results & F..
14/02/2025Quarterly Results
More